Pulmonology

Your Article Summary

See Latest Articles

Vaccines for the Treatment of Non-Small Cell Lung Cancer: A Renewed Anticancer Strategy
The Oncologist, 09/25/09

Gridelli C et al. – Carcinoma of the lung is the leading cause of cancer death worldwide, with non–small cell lung cancer (NSCLC) constituting about 85% of all new diagnoses. Standard approaches for each NSCLC stage have reached a plateau in effectiveness. A variety of novel approaches are now being investigated to improve the outcome of this disease. This paper reviews the main clinical trials involving several different cancer vaccines employed in the treatment of early and advanced stage NSCLC, focusing on those in advanced stages of development.

Related Articles

See all related articles

Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09    Relevance Score: 83%

HRQoL changes, mood disorders and satisfaction after treatment in an unselected population of patients with lung cancer
The Clinical Respiratory Journal, 11/13/09    Relevance Score: 82%

Image-Guided Radiofrequency Ablation of Lung Neoplasm in 100 Consecutive Patients by a Thoracic Surgical Service
Annals of Thoracic Surgery, 10/23/09    Relevance Score: 82%

Noninvasive detection of lung cancer by analysis of exhaled breath
BMC Cancer, 10/09/09    Relevance Score: 82%

CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians
Lung Cancer, 10/06/09    Relevance Score: 82%

Today in Lung/Thoracic Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

Gene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with Non–Small Cell Lung Cancer from Patients with Nonmalignant Lung Disease
Cancer Research, 12/18/09

A small-cell lung cancer genome with complex signatures of tobacco exposure
Nature, 12/18/09

Pain in patients with lung cancer: Pathophysiology and treatment
Lung Cancer, 12/18/09

 See all of Lung/Thoracic Oncology